EKSO Q3 2017 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q3 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$2M+0.1% YoY

Gross Profit

$544,00034.1% margin

Operating Income

-$7M-442.5% margin

Net Income

-$6M-396.7% margin

EPS (Diluted)

$-2.74

QoQ Revenue Growth

-14.5%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$650,000

Balance Sheet

Total Assets

$43M

Total Liabilities

$14M

Stockholders' Equity

$30M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+0.1%
Gross Profit	$544,000	$403,000	+35.0%
Operating Income	-$7M	-$7M	-2.9%
Net Income	-$6M	-$8M	+25.3%

Revenue Segments

Medical

$1M83%

Industrial

$267,00017%

Engineering Services

$10,0001%

Geographic Segments

United States

$1M71%

All Other

$467,00029%